如何引证项目

Research Progress in Corneal Cross-linking Agents

  
@article{YKXB3790,
	author = {Na Li 和 Xiujun Peng 和 Zhengjun Fan},
	title = {Research Progress in Corneal Cross-linking Agents},
	journal = {眼科学报},
	volume = {29},
	number = {2},
	year = {2016},
	keywords = {},
	abstract = {Corneal collagen cross-linking with UVA-riboflavin is currently the only method for preventing the progression of keratoconus from the pathological perspective. Topical application of a direct cross-linking agent is now attracting widespread attention in clinical settings..This article reviews the research progress in the application of indirect or direct cross-linking agents(e.g., riboflavin, glucose, ribose, glutaraldehyde,formaldehyde,.glyceraldehyde,.short chain aliphatic β-nitro alcohol, and genipin) in the treatment of corneal diseases and analyzes the cross-linking efficacy,.toxicity,.and merits and disadvantages of each cross-linking agent,.providing clinical information for further studies.},
	url = {https://ykxb.amegroups.com/article/view/3790}
}